In a letter to Amazon’s new CEO Andy Assy on July 26 from Donald Ashley, director of the FDA’s Office of Drug Assessment and Research (CDER) compliance, the agency said the FDA had bought “Dozens of products designed for sexual growth and weight loss”From website, “After further laboratory tests, it was found that all the tested products contain components of undeclared potentially harmful drugs. As discussed below, your company is responsible for introducing, delivering or introducing new drugs that are not accepted. ”

Twenty-six sexual enhancements were purchased between December 2019 and February 2020. All but one were sold as dietary supplements. The FDA said laboratory tests had determined their presence “Sildenafil, tadalafil և one or more components of vardenafil”. Amazon later told the FDA that the products were limited, but the agency was able to repurchase one of the products in January 2021, prompting the agency to express concern that Amazon’s filters “Insufficient”.

In March of this year, the agency “On your website,, you have purchased samples of two additional ‘enhancement և different weight մեկ weight loss products, all of which have been submitted or submitted to Amazon Interstate Trading through your Amazon service.”

The FDA analysis confirmed the presence of tadalafil in sexual enhancement products և the presence of sibutramine in weight loss products.